{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Diskus&page=3", "query": { "intervention": "Diskus", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 89, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Diskus&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Diskus&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-18T07:55:45.757Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01430403", "title": "Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Omalizumab", "type": "BIOLOGICAL" }, { "name": "Inhaled Corticosteroid Boost Therapy (ICS)", "type": "DRUG" }, { "name": "Placebo omalizumab", "type": "BIOLOGICAL" }, { "name": "Placebo fluticasone", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 478, "start_date": "2011-09", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-18T07:55:45.757Z", "location_count": 8, "location_summary": "Denver, Colorado • Washington D.C., District of Columbia • Chicago, Illinois + 5 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01430403" }, { "nct_id": "NCT00214019", "title": "The Effect of Salmeterol on Eosinophil (EOS) Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Allergic Asthma" ], "interventions": [ { "name": "salmeterol", "type": "DRUG" }, { "name": "Fluticasone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 36, "start_date": "2003-11", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2017-11-21", "last_synced_at": "2026-10-18T07:55:45.757Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00214019" }, { "nct_id": "NCT01110200", "title": "Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "ADVAIR DISKUS 250/50 mg BID", "type": "DRUG" }, { "name": "SEREVENT 50 mcg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 639, "start_date": "2010-04-30", "completion_date": "2012-05-08", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-10-18T07:55:45.757Z", "location_count": 74, "location_summary": "Birmingham, Alabama • Florence, Alabama • Mobile, Alabama + 66 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110200" }, { "nct_id": "NCT03034915", "title": "A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI 62.5/25 mcg via ELLIPTA", "type": "DRUG" }, { "name": "UMEC 62.5 mcg via ELLIPTA", "type": "DRUG" }, { "name": "Salmeterol 50 mcg via DISKUS", "type": "DRUG" }, { "name": "Placebo via ELLIPTA", "type": "DRUG" }, { "name": "Placebo via DISKUS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 2696, "start_date": "2017-06-16", "completion_date": "2018-06-18", "has_results": true, "last_update_posted_date": "2020-03-11", "last_synced_at": "2026-10-18T07:55:45.757Z", "location_count": 37, "location_summary": "Phoenix, Arizona • Lincoln, California • Clearwater, Florida + 34 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Lincoln", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03034915" }, { "nct_id": "NCT02061280", "title": "Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone/salmeterol 250/50 Dry Powder Inhaler", "type": "DRUG" }, { "name": "fluticasone/salmeterol 100/50 Dry Powder Inhaler", "type": "DRUG" }, { "name": "fluticasone 100mcg Dry Powder Inhaler", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nemours Children's Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 108, "start_date": "2013-10", "completion_date": "2017-02-17", "has_results": true, "last_update_posted_date": "2018-12-19", "last_synced_at": "2026-10-18T07:55:45.757Z", "location_count": 5, "location_summary": "Wilmington, Delaware • Jacksonville, Florida • Orlando, Florida + 2 more", "locations": [ { "city": "Wilmington", "state": "Delaware" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Pensacola", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02061280" }, { "nct_id": "NCT02175771", "title": "Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "FS MDPI", "type": "DRUG" }, { "name": "FLOVENT HFA", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" }, { "name": "albuterol/salbutamol HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 758, "start_date": "2014-07", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-18T07:55:45.757Z", "location_count": 101, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Pell City, Alabama + 85 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Pell City", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02175771" }, { "nct_id": "NCT02826343", "title": "New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Xenon129 MRI imaging", "type": "DRUG" }, { "name": "Gadolinium MRI", "type": "DRUG" }, { "name": "Advair (250mcg/50mcg) one puff twice a day", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 30, "start_date": "2016-05-01", "completion_date": "2018-06-15", "has_results": false, "last_update_posted_date": "2020-11-04", "last_synced_at": "2026-10-18T07:55:45.757Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02826343" }, { "nct_id": "NCT01436110", "title": "Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone furoate 50mcg", "type": "DRUG" }, { "name": "Fluticasone propionate 100mcg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 351, "start_date": "2011-09", "completion_date": "2012-09", "has_results": true, "last_update_posted_date": "2017-01-09", "last_synced_at": "2026-10-18T07:55:45.757Z", "location_count": 20, "location_summary": "Los Angeles, California • Rolling Hills Estates, California • Sacramento, California + 17 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01436110" }, { "nct_id": "NCT01868009", "title": "DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "ELLIPTA", "type": "DEVICE" }, { "name": "DISKUS", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 287, "start_date": "2013-05", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2014-03-04", "last_synced_at": "2026-10-18T07:55:45.757Z", "location_count": 17, "location_summary": "Jasper, Alabama • Riverside, California • Clearwater, Florida + 14 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Riverside", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Leesburg", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01868009" }, { "nct_id": "NCT03227445", "title": "Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "ELLIPTA placebo DPI", "type": "DEVICE" }, { "name": "DISKUS placebo DPI", "type": "DEVICE" }, { "name": "HandiHaler placebo DPI", "type": "DEVICE" }, { "name": "Inhaler preference questionnaires", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 240, "start_date": "2017-09-20", "completion_date": "2018-01-04", "has_results": true, "last_update_posted_date": "2020-07-08", "last_synced_at": "2026-10-18T07:55:45.757Z", "location_count": 18, "location_summary": "Orlando, Florida • Natchitoches, Louisiana • Saint Charles, Missouri + 14 more", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "Natchitoches", "state": "Louisiana" }, { "city": "Saint Charles", "state": "Missouri" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Gastonia", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03227445" } ] }